|
|
|
| Brand | Other Names | Presentation | Strengths | Enquire |
| Ferriprox ® | deferiprone | Tablets | 500mg x 100 |
| TGA indication | |
| FERRIPROX is indicated for the treatment of iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; or in whom desferrioxamine therapy has proven ineffective. | |
| PBS listing | |
| Section 100: Private hospital authority required. Iron overload in patients with thalassaemia major who are unable to take desferrioxamine therapy; Iron overload in patients with thalassaemia major in whom desferrioxamine therapy has proven ineffective. | |
| Information for Patients | |
| Consumer Medicine Information Tablets | |
| Consumer Medicine Information - Solution | |
| Information for Healthcare Professionals | |
| Product Information | |
